Nasdaq
GMAB
Genmab A/S
- Health Care
- Denmark
- Listed 2019
- 1 day
- +1.9%
- 1 month
- +2.2%
- 1 year
- +38.7%
$29.83 · Mkt cap $3.83B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Genmab A/S
$29.83 · Mkt cap $3.83B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Genmab A/S trades under the ticker GMAB on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2019. Its market capitalisation is $3.83B. The last closing price was $29.83, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +38.7%, and +2.2% over the past month. Returns are price returns and exclude dividends.
This page exists because GMAB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.